抗原抗体反応

WordNet

(mechanics) the equal and opposite force that is produced when any force is applied to a body; "every action has an equal and opposite reaction"
a response that reveals a persons feelings or attitude; "he was pleased by the audiences reaction to his performance"; "John feared his mothers reaction when she saw the broken lamp"
a bodily process occurring due to the effect of some antecedent stimulus or agent; "a bad reaction to the medicine"; "his responses have slowed with age" (同)response
doing something in opposition to another way of doing it that you dont like; "his style of painting was a reaction against cubism"
an idea evoked by some experience; "his reaction to the news was to start planning what to do"
extreme conservatism in political or social matters; "the forces of reaction carried the election"
any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)
any of a large variety of proteins normally present in the body or produced in response to an antigen which it neutralizes, thus producing an immune response

PrepTutorEJDIC

{名}(…に対する)『反応』《+『to』+『名』》 / 〈U〉(…に対する)(政治的・社会的な)『反動』,逆コース《+『against』+『名』》 / 〈U〉〈C〉化学反応,化学変化 / 〈U〉〈C〉(物理学で)反作用
抗原(生物の体内にはいって免疫体を作る物質)
抗体,免疫体,抗毒素

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/02/03 11:43:55」(JST)

wiki en

Antigen-antibody interaction, or antigen-antibody reaction, is a specific chemical interaction between antibodies produced by B cells of the white blood cells and antigens during immune reaction. It is the fundamental reaction in the body by which the body is protected from complex foreign molecules, such as pathogens and their chemical toxins. In the blood, the antigens are specifically and with high affinity bound by antibodies to form an antigen-antibody complex. The immune complex is then transported to cellular systems where it can be destroyed or deactivated.

The first correct description of the antigen-antibody reaction was given by Richard J. Goldberg at the University of Wisconsin in 1952.^[1]^[2] It came to be known as "Goldberg's theory" (of antigen-antibody reaction).^[3]

There are several types of antibodies and antigens, and each antibody is capable of binding only to a specific antigen. The specificity of the binding is due to specific chemical constitution of each antibody. The antigenic determinant or epitope is recognized by the paratope of the antibody, situated at the variable region of the polypeptide chain. The variable region in turn has hyper-variable regions which are unique amino acid sequences in each antibody. Antigens are bound to antibodies through weak and noncovalent interactions such as electrostatic interactions, hydrogen bonds, Van der Waals forces, and hydrophobic interactions.^[4]

The principles of specificity and cross-reactivity of the antigen-antibody interaction are useful in clinical laboratory for diagnositic purposes. One basic application is determination of ABO blood group. It is also used as a molecular technique for infection with different pathogens, such as HIV, microbes, and helminth parasites.

Antibody structure

In an antibody, the Fab (fragment, antigen-binding) region is formed from the amino-terminal end of both the light and heavy chains of the immunoglobulin polypeptide. This region called V (variable) domain is composed of amino acid sequences that define each type of antibody and their binding affinity to an antigen. The combined sequence of variable light chain (V_L) and variable heavy chain (V_H) creates three hypervariable regions (HV1, HV2, and HV3). In V_L these are roughly from residues 28 to 35, from 49 to 59, and from 92 to 103, respectively. HV3 is the most variable part. Thus these regions are the paratope, the binding site of antigen. The rest of the V region between the hypervariable regions are called framework regions. Each V domain has four framework domains, namely FR1, FR2, FR3, and FR4.^[4]^[5]

Properties

Chemical basis of antigen-antibody interaction

Antibodies bind antigens through weak chemical interactions, and bonding is essentially non-covalent. Electrostatic interactions, hydrogen bonds, van der Waals forces, and hydrophobic interactions are all known to be involved depending on the interaction sites.^[6]^[7]

Affinity of the interaction

Antigen and antibody interact through a high affinity binding much like lock and key.^[8] A dynamic equilibrium exists for the binding. For example, the reaction is a reversible one, and can be expressed as:

$[Ab]+[Ag]\leftrightharpoons [AbAg]$

where [Ab] is the antibody concentration and [Ag] is the antigen concentration, either in free ([Ab],[Ag]) or bound ([AbAg]) state.

The equilibrium association constant can therefore be represented as: $K_{a}={\frac {k_{on}}{k_{off}}}={\frac {[AbAg]}{[Ab][Ag]}}$

where K is the equilibrium constant.

Reciprocally the dissociation constant will be: $K_{d}={\frac {k_{off}}{k_{on}}}={\frac {[Ab][Ag]}{[AbAg]}}$

However, these equations are applicable only to a single epitope binding, i.e. one antigen on one antibody. Since the antibody necessarily has two paratopes, and in many circumstances complex binding occurs, the multiple binding equilibrium can be summed up as:

$K_{a}={\frac {k_{on}}{k_{off}}}={\frac {[AbAg]}{[Ab][Ag]}}$ = r/c(n-r)

where, at equilibrium, c is the concentration of free ligand, r represents the ratio of the concentration of bound ligand to total antibody concentration and n is the maximum number of binding sites per antibody molecule (the antibody valence).

The overall strength of the binding of an antibody to an antigen is termed its avidity for that antigen. Since antibodies are bivalent or polyvalent, this is the sum of the strengths of individual antibody-antigen interactions. The strength of an individual interaction between a single binding site on an antibody and its target epitope is termed the affinity of that interaction.

Avidity and affinity can be judged by the dissociation constant for the interactions they describe. The lower the dissociation constant, the higher the avidity or affinity, and the stronger the interaction.

Application

Antigen-antibody interaction is used in laboratory techniques for serological test of blood compatibility and various pathogenic infections. The most basic is ABO blood group determination, which is useful for blood transfusion.^[9] Sophisticated applications include ELISA,^[10] enzyme-linked immunospot (Elispot), immunofluorescence, and immunoelectrophoresis.^[11]^[12]^[13]

References

^ Goldberg, Richard J. (1952). "A Theory of Antibody—Antigen Reactions. I. Theory for Reactions of Multivalent Antigen with Bivalent and Univalent Antibody". Journal of the American Chemical Society. 74 (22): 5715–5725. doi:10.1021/ja01142a045.
^ Sahimi, Muhammad (1994). Applications of Percolation Theory. London: CRC Press. p. 257. ISBN 978-0-203-22153-2.
^ Spiers, JA (1958). "Goldberg's theory of antigen-antibody reactions in vitro". Immunology. 1 (2): 89–102. PMC 1423897. PMID 13538526.
^ ^a ^b Janeway, Charles A Jr; Travers, Paul; Walport, Mark; Shlomchik, Mark J (2001). Immunobiology: The Immune System in Health and Disease (5 ed.). New York: Garland Science. ISBN 0-8153-3642-X.
^ Mian, I.Saira; Bradwell, Arthur R.; Olson, Arthur J. (1991). "Structure, function and properties of antibody binding sites". Journal of Molecular Biology. 217 (1): 133–151. doi:10.1016/0022-2836(91)90617-F. PMID 1988675.
^ van Oss, CJ; Good, RJ; Chaudhury, MK (1986). "Nature of the antigen-antibody interaction. Primary and secondary bonds: optimal conditions for association and dissociation". Journal of Chromatography. 376: 111–9. PMID 3711190.
^ Absolom, DR; van Oss, CJ (1986). "The nature of the antigen-antibody bond and the factors affecting its association and dissociation". CRC Critical Reviews in Immunology. 6 (1): 1–46. PMID 3522103.
^ Braden, BC; Dall'Acqua, W; Eisenstein, E; Fields, BA; Goldbaum, FA; Malchiodi, EL; Mariuzza, RA; Schwarz, FP; Ysern, X; Poljak, RJ (1995). "Protein motion and lock and key complementarity in antigen-antibody reactions.". Pharmaceutica acta Helvetiae. 69 (4): 225–30. doi:10.1016/0031-6865(94)00046-x. PMID 7651966.
^ Mayer, Gene. "Immunoglobulins- antigen-antibody reactions and selected tests". Microbiology and Immunology. University of South Carolina School of Medicine. Retrieved 10 March 2015.
^ Margolis, Simeon (5 January 2012). "Antigen/Antibody Tests for Infectious Disease". Remedy Health Media, LLC. Retrieved 10 March 2015.
^ Taylor, Charles W.; Chakrabarty, Subhas; Schauder, Keith S.; Yeoman, Lynn C. (1983). "Identification of Cytosolic Antigens from GW-39 Adenocarcinoma Cells by Crossed Immunoelectrophoresis and Immunofluorescence". Immunological Investigations. 12 (3): 315–329. doi:10.3109/08820138309050753.
^ Ferenčík, Miroslav (2013). Handbook of Immunochemistry. Netherlands: Springer. pp. 309–386. doi:10.1007/978-94-011-1552-0_12. ISBN 978-94-010-4678-7.
^ Odell, Ian D; Cook, Deborah (2013). "Immunofluorescence Techniques". Journal of Investigative Dermatology. 133 (1): e4. doi:10.1038/jid.2012.455.

External links

Antigen-antibody reaction
Discover Biotech

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 免疫グロブリンの機能および臨床応用 function and clinical applications of immunoglobulins
2. 急性輸血反応が疑われる患者に対するアプローチ approach to the patient with a suspected acute transfusion reaction
3. 薬物アレルギー：分類および臨床的特徴 drug allergy classification and clinical features
4. 癌治療に用いられる治療用モノクローナル抗体に対する輸注反応 infusion reactions to therapeutic monoclonal antibodies used for cancer therapy
5. Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy

English Journal

Development of interdigitated arrays coated with functional polyaniline/MWCNT for electrochemical biodetection: Application for human papilloma virus.

Tran LD, Nguyen DT, Nguyen BH, Do QP, Le Nguyen H.SourceInstitute of Materials Science, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet Road, Ha Noi, Viet Nam.
Talanta.Talanta.2011 Sep 15;85(3):1560-5. Epub 2011 Jun 23.
In this study, polyaniline-multiwalled carbon nanotube film (PANi-MWCNT) has been polymerized on interdigitated platinum electrode arrays (IDA), fabricated by MEMS technology for the detection of human papillomavirus (HPV) infection, using immobilized peptide aptamers as affinity capture reagent. La
PMID 21807222

Dry-reagent gold nanoparticle-based lateral flow biosensor for the simultaneous detection of Vibrio cholerae serogroups O1 and O139.

Yu CY, Ang GY, Chua AL, Tan EH, Lee SY, Falero-Diaz G, Otero O, Rodriguez I, Reyes F, Acosta A, Sarmiento ME, Ghosh S, Ramamurthy T, Yean Yean C, Lalitha P, Ravichandran M.SourceDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
Journal of microbiological methods.J Microbiol Methods.2011 Sep;86(3):277-82. Epub 2011 May 6.
Cholera is a communicable disease caused by consumption of contaminated food and water. This potentially fatal intestinal infection is characterised by profuse secretion of rice watery stool that can rapidly lead to severe dehydration and shock, thus requiring treatment to be given immediately. Epid
PMID 21571011

Japanese Journal

Detection of antigen-antibody reaction using Si ring optical resonators functionalized with an immobilized antibody-binding protein (Special issue: Solid state devices and materials)

Fukuyama Masataka,Nishida Mizue,Abe Yosuke [他]
Japanese journal of applied physics 50(4), 04DL07-1-3, 2011-04
NAID 40018801061

放射光によるフッ素樹脂製多機能フィルターの作製とイムノアッセイチップへの応用

浮田芳昭,近藤沙妃,武尾正弘,根来誠司,片岡千和,内海裕一
電気学会論文誌. C, 電子・情報・システム部門誌 = The transactions of the Institute of Electrical Engineers of Japan. C, A publication of Electronics, Information and System Society 130(10), 1756-1761, 2010-10-01
… This result suggests the successful immobilization of antibody (anti-mouse IgG goat antibody) onto the x-ray exposed surface of PTFE microstructue and successful demonstration of antigen-antibody reaction in the PTFE high-aspect ratio microstructure. …
NAID 10026694072